These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1759983)

  • 41. Intra- and interindividual variability of hemostatic factors and traditional cardiovascular risk factors in a three-year follow-up.
    Salomaa V; Rasi V; Stengård J; Vahtera E; Pekkanen J; Vartiainen E; Ehnholm C; Puska P
    Thromb Haemost; 1998 May; 79(5):969-74. PubMed ID: 9609231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemostatic risk factors in ischemic stroke.
    Demarmels Biasiutti F; Berger D; Mattle HP; Lämmle B; Wuillemin WA
    Thromb Haemost; 2003 Dec; 90(6):1094-9. PubMed ID: 14652642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic importance of haemostatic parameters in polyarterial disease.
    Bosevski M; Kostoska S; Tosev S; Borozanov V
    Prilozi; 2005 Aug; 26(1):81-92. PubMed ID: 16118617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The influence of age and smoking on hemostatic parameters in the chinese people.
    Ho CH
    Thromb Res; 1995 Jun; 78(6):495-503. PubMed ID: 15714751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
    Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Lipid-metabolic and blood coagulation factors in chronic peripheral arteriopathies].
    Di Martino G; Matarazzo A; Auriemma L; Rosati V; Florio A; Iannucci F
    Quad Sclavo Diagn; 1983 Mar; 19(1):134-40. PubMed ID: 6675043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Behavior of various blood coagulation and hemorrheological parameters in arteriosclerotic vascular disease of the lower legs].
    Avellone G; Mandalà V; Novo S; Pinto A; Davì G; Raneli G; Strano A
    Ric Clin Lab; 1983; 13 Suppl 3():297-301. PubMed ID: 6200915
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD-study.
    Breddin HK; Krzywanek HJ; Althoff P; Kirchmaier CM; Rosak C; Schepping M; Weichert W; Ziemen M; Schöffling K; Uberla K
    Int Angiol; 1986; 5(3):181-95. PubMed ID: 3104511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study.
    Violi F; Criqui M; Longoni A; Castiglioni C
    Atherosclerosis; 1996 Feb; 120(1-2):25-35. PubMed ID: 8645368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hemostatic tests in the prediction of atherothrombotic disease.
    Wu KK
    Int J Clin Lab Res; 1997; 27(3):145-52. PubMed ID: 9352376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are hemostatic factors responsible for the paradoxical risk factors for coronary heart disease and stroke?
    Gliksman M; Wilson A
    Stroke; 1992 Apr; 23(4):607-10. PubMed ID: 1561696
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Congenital disorders of hemostasis in children with Perthes disease].
    Kandzierski G; Malek U; Gregosiewicz A; Okoński M; Filiks-Litwin B; Drabko K
    Chir Narzadow Ruchu Ortop Pol; 2004; 69(4):225-7. PubMed ID: 15587376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The role of plasma lipids and of coagulation factors in atherosclerosis. Clinical trials and new prospects].
    Pagano G; Niort G
    Cardiologia; 1991 Dec; 36(12 Suppl 1):25-32. PubMed ID: 1841778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia.
    Barton MH; Morris DD; Norton N; Prasse KW
    J Vet Intern Med; 1998; 12(1):26-35. PubMed ID: 9503357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An epidemiological study of the haemostatic and other effects of oral contraceptives.
    Meade TW; Brozović M; Chakrabarth R; Howarth DJ; North WR; Stirling Y
    Br J Haematol; 1976 Nov; 34(3):353-64. PubMed ID: 990177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
    Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antithrombin III and factor Xa inhibitor in atherosclerosis.
    Marra R; Pagano L; De Stefano V; Bizzi B
    Haemostasis; 1983; 13(4):209-13. PubMed ID: 6618288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease.
    Cavusoglu Y; Gorenek B; Alpsoy S; Unalir A; Ata N; Timuralp B
    Isr Med Assoc J; 2001 Jan; 3(1):13-6. PubMed ID: 11344793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blood coagulation and fibrinolysis in patients with hyperthyroidism.
    Erem C; Ersoz HO; Karti SS; Ukinç K; Hacihasanoglu A; Değer O; Telatar M
    J Endocrinol Invest; 2002 Apr; 25(4):345-50. PubMed ID: 12030606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.